Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.25.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 917,927 $ 965,258 $ 1,222,940
Cost of goods sold 883,014 955,536 1,207,287
Gross profit 34,913 9,722 15,653
Selling, general and administrative expenses (27,208) (29,736) (29,864)
Acquisition-related recoveries (expenses) 460 (7,701) (2,800)
Gain (loss) on sale of assets 830 (293)
Asset impairments (803) (24,790) (6,544)
Income (loss) from operations 7,362 (51,675) (23,848)
Transferable tax credits, net 7,500
Excess insurance proceeds 6,688
Income from cash grant 2,812
Interest expense, net (10,765) (7,644) (7,425)
Other income, net 1,932 508 553
Income (loss) before provision (benefit) for income taxes 12,717 (58,811) (27,908)
Provision (benefit) for income taxes (621) 173 97
Consolidated net income (loss) 13,338 (58,984) (28,005)
Preferred stock dividends (1,265) (1,269) (1,265)
Income (loss) attributable to common stockholders $ 12,073 $ (60,253) $ (29,270)
Income (loss) per share, basic (in Dollars per share) $ 0.16 $ (0.82) $ (0.4)
Income (loss) per share, diluted (in Dollars per share) $ 0.16 $ (0.82) $ (0.4)
Weighted-average shares outstanding, basic (in Shares) 74,507,000 73,482,000 73,339,000
Weighted-average shares outstanding, diluted (in Shares) 75,663,000 73,482,000 73,339,000